Zepbound, marketed and sold in the United States, is manufactured by Eli Lilly at multiple facilities in the United States
The cardiovascular benefits observed with these medications include: Reduction in non-fatal myocardial infarction and stroke Decreased cardiovascular mortality in high-risk populations (demonstrated with liraglutide) Improvements in blood pressure and lipid profiles Weight reduction , which independently lowers cardiovascular risk It is important to distinguish between arterial thrombotic events (such as heart attacks and strokes, which some GLP-1 agonists help prevent) and venous thromboembolism (DVT and PE)
Ongoing Support Options After Treatment Ends Some patients achieve stable weight loss after tirzepatide and maintain it indefinitely with lifestyle alone, while others benefit from long-term low-dose maintenance therapy
It might also improve your health in other ways that are still being understood
As of now, tirzepatide is not recommended for use in pregnant women because there isnt enough research on how it affects the baby
If you are eligible for semaglutide injections, we will get you set up with the proper prescription